Biomea Fusion, Inc. (BMEA) Discusses Phase I Data and Clinical Potential of Oral GLP-1 Receptor Antagonist for Obesity Transcript By Vast Inferno · March 30, 2026 · 1 min read bmeasa transcripts Source: seekingalpha.com